Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue May 2015
 •  Palmers Casts Hewitt for Fall Campaign  •  UPDATE: P&G Sells Frédéric Fekkai  •  Novex Expands With Curls Collection  •  Net-A-Porter Picks Up Goldfaden MD  •  Spectrum Buys Armor All
Print

Symrise Takes Stake in U.S. BioTech Firm



Published October 7, 2008
Related Searches: care president scent active
Post a comment
Symrise has acquired a 20% stake Therapeutic Peptides Inc. (TPI), a New Orleans, LA-based biotechnology company, giving it exclusive distribution rights for advanced cosmetic active ingredients, including peptides.

“We are delighted to be able to integrate these modern and very effective ingredients in our portfolio. With TPI, we have found a partner who is developing these ingredients at a scientifically exalted level and can offer ample expertise in this field,” said Dr. Klaus Stanzl, president, scent and care, Life Essentials.

More info: www.symrise.com


blog comments powered by Disqus